Matrine combined with cyclosporin A alleviates acute graft-versus-host-disease after allogeneic bone marrow transplantation in a murine model

Zhang Yan,Wang Yi-ni,Feng Cui-cui,Tian Li-ping,Li Fang,Wang Zhao
DOI: https://doi.org/10.3969/j.issn.1673-8225.2011.44.025
2011-01-01
Abstract:BACKGROUND: Matrine can decrease the concentration of interleukin (IL-2) and has been used as a chemotherapy auxiliary medicine in the clinic. OBJECTIVE: To investigate the effects of matrine and cyclosporin A (CsA) on acute graft-versus-host-disease (aGVHD) after allogenetic bone marrow transplantation and the possible mechanism of matrine. METHODS: The donors were male C57BL/6 mice, and the recipients were male BABL/C mice. The model of aGVHD in murine was established by allo-BMT with donor derived T cells. The aGVHD models were randomly divided into seven groups: control, radiation, transplantation, fully quantity CsA, half quantity CsA, full quantity matrine, full quantity matrine and half quantity CsA. RESULTS AND CONCLUSIONS: The mouse survival time in the full quantity matrine and half quantity CsA group was longer than the other groups. Different degrees of pathological changes in aGVHD appeared in each group, and earlier aGVHD occurrence led to more severe pathological change. At 7 days after transplantation, compared with transplantation group, serum level of γ-interferon was decreased in other groups, but there was no significant difference in IL-4 level between transplantation and other groups. These findings suggest that matrine can prevent lethal aGNHD and prolong mouse survival time after allogenetic bone marrow transplantation. Matrine exhibits similar effects to CsA, and their combination show better effects than alone.
What problem does this paper attempt to address?